about
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel c...
Read More
53.01
1.53
(2.97%)
1.9M
XNAS Volume
XNAS 08 May, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for Vaxcyte Inc is scheduled for today, for the purpose of Vaxcyte Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Vaxcyte Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..